Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells

Biorheology

Volumn 46, Issue 4, 2009, Pages 323-341

  Calderon, Andres J ^a   Muzykantov, Vladimir ^a   Muro, Silvia ^a,b   Eckmann, David M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

Drug delivery; Endothelium; ICAM targeting; Particles; Targeted delivery

Indexed keywords

DRUG CARRIER; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;

ARTICLE; BLOOD FLOW; CELL ACTIVATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOTHELIUM CELL; FLOW KINETICS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PARAMETER; PATHOLOGY; SHEAR RATE; SHEAR STRESS; SURFACE PROPERTY; THEORETICAL MODEL;

ANTIBODIES, MONOCLONAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1;

EID: 70349085343     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: 10.3233/BIR-2009-0544     Document Type: Article

References (60)

1. N.J. Agrawal and R. Radhakrishnan, The role of glycocalyx in nanocarrier-cell adhesion investigated using a thermodynamic model and Monte Carlo simulations, J. Phys. Chem. C 111 (2007), 15848-15856.
2. M.E. Anderson and T.J. Siahaan, Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors, Peptides 24 (2003), 487-501.
3. G.I. Bell, Models for the specific adhesion of cells to cells, Science 200 (1978), 618-627.
4. J.E. Blackwell, N.M. Dagia, J.B. Dickerson, E.L. Berg and D.J. Goetz, Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions, Ann. Biomed. Eng. 29 (2001), 523-533.
5. P.G. Bloemen, P.A. Henricks, L. van Bloois, M.C. van den Tweel et al., Adhesion molecules: a new target for immunoliposome-mediated drug delivery, FEBS Lett. 357 (1995), 140-144.
6. S. Chen, R. Alon, R.C. Fuhlbrigge and T.A. Springer, Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins, PNAS USA 94 (1997), 3172-3177.
7. D.B. Cines, E.S. Pollak, C.A. Buck, J. Loscalzo et al., Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood 91 (1998), 3527-3561.
8. C. Cozens-Roberts, J.A. Quinn and D.A. Lauffenburger, Receptor-mediated cell attachment and detachment kinetics. II. Experimental model studies with the radial flow detachment assay, Biophys. J. 58 (1990), 857-872.
9. M.I. Cybulsky and M.A. Gimbrone Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis, Science 251 (1991), 788-791.
10. S.M. Danilov, V.D. Gavrilyuk, F.E. Franke, K. Pauls et al., Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting, Am. J. Physiol. Lung Cell Mol. Physiol. 280 (2001), L1335-L1347.
11. P. Decuzzi and M. Ferrari, The adhesive strength of non-spherical particles mediated by specific interactions, Biomaterials 27 (2006), 5307-5314.
12. P. Decuzzi, R. Pasqualini, W. Arap and M. Ferrari, Intravascular delivery of particulate systems: does geometry really matter?, Pharm. Res. 26 (2009), 235-243.
13. B.S. Ding, T. Dziubla, V.V. Shuvaev, S. Muro and V.R. Muzykantov, Advanced drug delivery systems that target the vascular endothelium, Mol. Interv. 6 (2006), 98-112.
14. A.O. Eniola and D.A. Hammer, Artificial polymeric cells for targeted drug delivery, J. Control Release 87 (2003), 15-22.
15. A.O. Eniola, E.F. Krasik, L.A. Smith, G. Song and D.A. Hammer, I-Domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow, Biophys. J. 89 (2005), 3577-3588.
16. A.O. Eniola, S.D. Rodgers and D.A. Hammer, Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes, Biomaterials 23 (2002), 2167-2177.
17. A.O. Eniola, P.J. Willcox and D.A. Hammer, Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs, Biophys. J. 85 (2003), 2720-2731.
18. C. Garnacho, R. Dhami, E. Simone, T. Dziubla et al., Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers, J. Pharmacol. Exp. Ther. 325 (2008), 400-408.
19. M.A. Gimbrone Jr., Vascular endothelium, hemodynamic forces, and atherogenesis, Am. J. Pathol. 155 (1999), 1-5.
20. A. Goldman, R. Cox and H. Brenner, Slow viscous motion of a sphere parallel to a plane wall. II. Couette flow, Chem. Eng. Sci. 22 (1967), 653.
21. A.S. Ham, D.J. Goetz, A.L. Klibanov and M.B. Lawrence, Microparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow, Biotech. Bioeng. 96 (2007), 596-607.
22. S.D. Jois and T.J. Teruna, A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein, J. Biomol. Struct. Dyn. 20 (2003), 635-644.
23. M.F. Kiani, H. Yuan, X. Chen, L. Smith et al., Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules, Pharm. Res. 19 (2002), 1317-1322.
24. A.M. Malek, G.H. Gibbons, V.J. Dzau and S. Izumo, Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium, J. Clin. Invest. 92 (1993), 2013-2021.
25. A.M. Malek and S. Izumo, Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress, J. Cell Sci. 109 (1996), 713-726.
26. S.D. Marlin and T.A. Springer, Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1), Cell 51 (1987), 813-819.
27. B.T. Marshall, M. Long, J.W. Piper, T. Yago et al., Direct observation of catch bonds involving cell-adhesion molecules, Nature 423 (2003), 190-193.
28. D. McQuarrie, Kinetics of small systems. I, J. Chem. Phys. 38 (1963), 433-435.
29. G. Molema, Tumor vasculature directed drug targeting: applying new technologies and knowledge to the development of clinically relevant therapies, Pharm. Res. 19 (2002), 1251-1258.
30. N.W. Moore and T.L. Kuhl, The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces, Biophys. J. 91 (2006), 1675-1687.
31. N.W. Moore, D.J. Mulder and T.L. Kuhl, Adhesion from tethered ligand-receptor bonds with microsecond lifetimes, Langmuir 24 (2008), 1212-1218.
32. M.S. Mulligan, A.A. Vaporciyan, M. Miyasaka, T. Tamatani and P.A. Ward, Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1, Am. J. Pathol. 142 (1993), 1739-1749.
33. J.C. Murciano, S. Muro, L. Koniaris, M. Christofidou-Solomidou et al., ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface, Blood 101 (2003), 3977-3984.
34. S. Muro, VCAM-1 and ICAM-1, in: Endothelial Biomedicine, W.C. Aird, ed., Cambridge University Press, NYC, NY, 2007, pp. 1058-1070.
35. S. Muro, X. Cui, C. Gajewski, J.C. Murciano et al., Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress, Am. J. Physiol. Cell Physiol. 285 (2003), C1339-C1347.
36. S. Muro, T. Dziubla, W. Qiu, J. Leferovich et al., Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1, J. Pharmacol. Exp. Ther. 317 (2006), 1161-1169.
37. S. Muro, C. Gajewski, M. Koval and V.R. Muzykantov, ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs, Blood 105 (2005), 650-658.
38. S. Muro, C. Garnacho, J.A. Champion, J. Leferovich et al., Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers, Mol. Ther. 16 (2008), 1450-1458.
39. S. Muro, M. Mateescu, C. Gajewski, M. Robinson et al., Control of intracellular trafficking of ICAM-1-targeted nanocar-riers by endothelial Na+/H+ exchanger proteins, Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006), L809-L817.
40. S. Muro and V.R. Muzykantov, Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules, Curr. Pharm. Des. 11 (2005), 2383-2401.
41. S. Muro, E.H. Schuchman and V.R. Muzykantov, Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis, Mol. Ther. 13 (2006), 135-141.
42. S. Muro, R. Wiewrodt, A. Thomas, L. Koniaris et al., A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1, J. Cell Sci. 116 (2003), 1599-1609.
43. V. Muzykantov, Targeting drugs to pulmonary endothelium, Exp. Opin. Drug Deliv. 2 (2005), 909-926.
44. P. Oh, P. Borgstrom, H. Witkiewicz, Y. Li, B.J. Borgstrom et al., Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung, Nat. Biotechnol. 25 (2007), 327-337.
45. J.W. Piper, R.A. Swerlick and C. Zhu, Determining force dependence of two-dimensional receptor-ligand binding affinity by centrifugation, Biophys. J. 74 (1998), 492-513.
46. A.R. Prasad, S.A. Logan, R.M. Nerem, C.J. Schwartz and E.A. Sprague, Flow-related responses of intracellular inositol phosphate levels in cultured aortic endothelial cells, Circ. Res. 72 (1993), 827-836.
47. M. Remy, N. Valli, D. Brethes, C. Labrugere et al., In vitro and in situ intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells lining a polyester fabric, Biomaterials 20 (1999), 241-251.
48. H.S. Sakhalkar, M.K. Dalal, A.K. Salem, R. Ansari et al., Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo, PNAS USA 100 (2003), 15895-15900.
49. E.A. Simone, T.D. Dziubla and V.R. Muzykantov, Polymeric carriers: role of geometry in drug delivery, Exp. Opin. Drug Deliv. 5 (2008), 1283-1300.
50. L.A. Smith, H. Aranda-Espinoza, J.B. Haun, M. Dembo and D.A. Hammer, Neutrophil traction stresses are concentrated in the uropod during migration, Biophys. J. 92 (2007), L58-L60.
51. L.A. Smith, H. Aranda-Espinoza, J.B. Haun and D.A. Hammer, Interplay between shear stress and adhesion on neutrophil locomotion, Biophys. J. 92 (2007), 632-640.
52. V.P. Torchilin, Drug targeting, Eur. J. Pharm. Sci. 11(Suppl. 2) (2000), S81-S91.
53. E. Tzima, M.A. Del Pozo, W.B. Kiosses, S.A. Mohamed et al., Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression, EMBO J. 21 (2002), 6791-6800.
54. F.S. Villanueva, R.J. Jankowski, S. Klibanov, M.L. Pina et al., Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells, Circulation 98 (1998), 1-5.
55. M. Voinea, I. Manduteanu, E. Dragomir, M. Capraru and M. Simionescu, Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells - a potential tool for specific drug delivery, Pharm. Res. 22 (2005), 1906-1917.
56. R.E. Weiner, D.E. Sasso, M.A. Gionfriddo, S.I. Syrbu et al., Early detection of bleomycin-induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1, J. Nucl. Med. 39 (1998), 723-728.
57. G.E. Weller, E. Lu, M.M. Csikari, A.L. Klibanov et al., Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1, Circulation 108 (2003), 218-224.
58. G.E. Weller, F.S. Villanueva, A.L. Klibanov and W.R. Wagner, Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium, Ann. Biomed. Eng. 30 (2002), 1012-1019.
59. R. Wiewrodt, A.P. Thomas, L. Cipelletti, M. Christofidou-Solomidou et al., Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells, Blood 99 (2002), 912-922.
60. N. Zhang, C. Chittasupho, C. Duangrat, T.J. Siahaan and C. Berkland, PLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1, Bioconjug. Chem. 19 (2008), 145-152.